GLUE

GLUE Other Income/Expenses (Net)

$17.88MTTM · USD

Period ending:

GLUE FY Other Income/Expenses (Net)USD
GLUE FY Other Income/Expenses (Net)2019-12-31: $254.00K2020-12-31: -$7.87M2021-12-31: -$1.08M2022-12-31: $3.88M2023-12-31: $8.30M2024-12-31: $10.98M2025-12-31: $14.49M$14.49M-$7.87M
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GLUE other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Monte Rosa Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
14,485,000
10,982,000
8,297,000
3,883,000
-1,076,000
-7,869,000
254,000

Compare other income/expenses (net)

All GLUE financial metrics · GLUE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.